Therefore, TOP2 inhibitors can be combined with drugs inhibiting the checkpoint kinase pathways and administered to force cancer cells to bypass cell cycle arrest and enter mitosis with DNA damage, which leads to mitotic catastrophe [38,39]. The gene discussed is TOP2A; the disease is cancer.